[1] WANDLAW JM,SMITH C,DICHGANS M.Mechanisms of sporadic cerebral small vessel disease:insights from neuroimaging[J].Lancet Neurol,2013,12(5):483.
[2] PANTONI L.Cerebral small vessel disease:from pathogenesis and clinical characteristics to therapeutic challenges[J].Lancet Neurol,2010,9(7):689.
[3] THOMPSON CS,HAKIM AM.Living beyond our physiological means:small vessel disease of the brain is an expression of a systemic failure in arteriolar function:a unifying hypothesis[J].Stroke,2009,40(5):e322.
[4] GORELICK PB,SCUTERI A,BLACK SE,et al.Vascular contributions to cognigtive impairment and dementia:a statement for healthcare professionals from the American Heart Association/American Stroke Association[J].Stroke,2011,42(9):2672.
[5] HACKE W,KASTE M,BLUHMKI E,et al.Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke[J].N Engl J Med,2008,359(13):1317.
[6] IST-3 collaborative group,SANDEREOCK P,WARDLAW JM,et al.The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke(the third international stroke trial[IST-3]):a randomized controlled trial[J].Lancet,2012,379(9834):2352.
[7] NEUMANN-HAEFELIN T,HOELIG S,BERKEFELD J,et al.Leukoaraiosis is a risk factor for symptomatic intracerebral hemorrhage after thrombolysis for acute stroke[J].Stroke,2006,37(10):2463.
[8] PALUMBO V,BOULANGER JM,HILL MD,et al.Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke[J].Neurology,2007,68(13):1020.
[9] PANTONI L,FIERINI F,POGGESI A.Thrombolysis in acute stroke patients with cerebral small vessel disease[J].Cerebrovasc Dis,2014,37(1):5.
[10] 中国脑小血管病诊治专家组.脑小血管病诊治专家共识[J].中华内科杂志,2013,52(10):893.
[11] BATH PM,WARDLAW JM.Pharmacological treatment and prevention of cerebral small vessel disease:a review of potential interventions[J].Int J Stroke,2015,10(4):469.
[12] BENAVENTE OR,HART RG,MCCLURE LA,et al.Effects of clopidogrel added to aspirin in patients with recent lacunar stroke[J].N Engl J Med,2012,367(9):817.
[13] PÉRGOLA PE,WHITE CL,GRAVES JW,et al.Reliability and validity of blood pressure measurement in the Secondary Prevention of Small Subcortical Strokes study[J].Blood Press Monit,2007,12(1):1.
[14] WANG YJ,WANG YL,ZHAO XQ,et al.Clopidogrel with aspirin in acute minor stroke or transient ischemic attack[J].N Engl J Med,2013,369(1):11.
[15] KAVIRAJAN H,SCHNEIDER LS.Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia:a meta-analysis of randomized controlled trials[J].Lancet Neurol,2007,6(9):782.
[16] MÖBIUS HJ,STÖ FFLER A.New approaches to clinical trials in vascular dementia:memantine in small vessel disease[J].Cerebrovasc Dis,2012,13(Suppl 2):61.
[17] WILCOCK G,MÖBIUS HJ,STÖFFLER A.A double-blind,placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500)[J].Int Clin Psychopharmacol,2002,17(6):297.
[18] PANTONI L,DEL SER T,SOGLIAN AG,et al.Efficacy and safety of nimodipine in subcortical vascular dementia:a randomized placebo-controlled trial[J].Stroke,2005,36(3):619.
[19] MORAN C,PHAN TG,SRIKANTH VK.Cerebral small vessel disease:a review of clinical,radiological,and histopathological phenotypes[J].Int J Stroke,2012,7(1):36.
[20] GORELICK PB,SCUTERI A,BLACK SE,et al.Vascular contributions to cognitive impairment and dementia:a statement for healthcare professionals from the american heart association/american stroke association[J].Stroke,2011,42(9):2672.
[21] HEYE AK,THRIPPLETON MJ,CHAPPELL FM,et al.Blood pressure and sodium:association with MRI markers in cerebral small vessel disease[J].J Cereb Blood Flow Metab.doi:10.1038/jcbfm.2015.64.
[22] FLAHERTY ML,WOO D,HAVERBUSCH M,et al.Racial variations in location and risk of intracerebral hemorrhage[J].Stroke,2005,36(5):934.
[23] DECARLI C.Blood pressure control and cognitive performance:something to think about with aging[J].JAMA,2015,313(19):1963.
[24] SABAYAN B,WESTENDORP RG.Blood pressure control and cognitive impairment-why low is not always better[J].JAMA Intern Med,2015,175(4):586.
[25] YAMAGUCHI Y,WADA M,SATO H,et al.Impact of ambulatory blood pressure variability on cerebral small vessel disease progression and cognitive decline in community-based elderly Japanese[J].Am J Hypertens,2014,27(10):1257.
[26] STAALS J,VAN OOSTENBRUGGE RJ,KNOTTNERUS IL,et al.Brain microbleeds relate to higher ambulatory blood pressure levels in first-ever lacunar stroke patients[J].Stroke,2009,40(10):3264.
[27] AMARENCO P,BENAVENTE O,GOLDSTEIN LB,et al.Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes[J].Stroke,2009,40(4):1405.
[28] MOK VC,LAM WW,FAN YH,et al.Effects of statins on the progression of cerebral white matter lesion:post hoc analysis of the ROCAS (Regression of Cerebral Artery Stenosis) study[J].J Neurol,2009,256(5):750.
[29] CHEN N,YANG M,GUO J,ZHOU M,et al.Cerebrolysin for vascular dementia[J].Cochrane Database Syst Rev,2013,33(7):CD008900.
[30] VITAOPS Trial Study Group.B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial:a randomised,double-blind,parallel,placebo-controlled trial[J].Lancet Neurol,2010,9(9):855.
[31] CAVALIERI M,SCHMIDT R,CHEN C,et al.B vitamins and magnetic resonance imaging-detected ischemic brain lesions in patients with recent transient ischemic attack or stroke:the VITAmins TO Prevent Stroke (VITATOPS) MRI-substudy[J].Stroke,2012,43(12):3266.
[32] KNOTTNERUS IL,TEN CATE H,LODDER J,et al.Endothelial dysfunction in lacunar stroke:a systematic review[J].Cerebrovasc Dis,2009,27(5):519.
[33] FARRALL AJ,WARDLAW JM.Blood-brain barrier:ageing and microvascular disease systematic review and meta-analysis[J].Neurobiol Aging,2009,30(3):337.
[34] WARDLAW JM,SMITH EE,BIESSELS GJ,et al.Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration[J].Lancet Neurol,2013,12(8):822.
[35] HAINSWORTH AH,OMMEN AT,BRIDGES LR.Endothelial cells and human cerebral small vessel disease[J].Brain Pathol,2015,25(1):44.